Chronic inhibition of cyclic GMP phosphodiesterase 5A prevents and reverses cardiac hypertrophy
Nature Medicine2005Vol. 11(2), pp. 214–222
Citations Over TimeTop 1% of 2005 papers
Eiki Takimoto, Hunter C. Champion, Manxiang Li, Diego Belardi, Shuxun Ren, E. René Rodríguez, Djahida Bedja, Kathleen L. Gabrielson, Yibin Wang, David A. Kass
Related Papers
- → Overview of phosphodiesterase 5 inhibition in erectile dysfunction(2003)203 cited
- → Exploring the Multifaceted Potential of Sildenafil in Medicine(2023)26 cited
- → Allosteric sites of phosphodiesterase‐5 (PDE5)(2001)87 cited
- → Role of NO-cGMP-PKG axis in pulmonary arterial hypertension(2022)10 cited
- → Nitric Oxide-cGMP-PKG Signaling in the Cardioprotective Effects of Phosphodiesterase 5 Inhibitors(2023)1 cited